Wuhan Feicheer Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Wuhan Feicheer Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include IMOLAZA. The owner is based in Wuhan, Hubei.

7-H327,7F,Bldg.1,Liming Jidian Ind. Park

Changzui Vil.,Canglongdao,Jiangxia Dist.

Wuhan, Hubei 430202 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IMOLAZA
IMOLAZA
Registered 2021

Trademark Classifications

Wuhan Feicheer Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Wuhan Feicheer Technology Co., Ltd. have?

Wuhan Feicheer Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Wuhan Feicheer Technology Co., Ltd. file in?

Wuhan Feicheer Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Wuhan Feicheer Technology Co., Ltd.'s most well-known trademarks?

Wuhan Feicheer Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as IMOLAZA. These are among 1 currently registered trademark in the portfolio.

What is Wuhan Feicheer Technology Co., Ltd.'s trademark registration success rate?

Wuhan Feicheer Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.